切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2019, Vol. 13 ›› Issue (03) : 180 -183. doi: 10.3877/cma.j.issn.1674-0793.2019.03.003

所属专题: 文献

论著

人肝癌组织原代巨噬细胞的提取与鉴定
梁浩1, 谢炬平1, 黄镇辉1, 张大伟1, 蒋小峰1, 薛平1,()   
  1. 1. 510260 广州医科大学附属第二医院肝胆胰外科
  • 收稿日期:2019-01-28 出版日期:2019-06-01
  • 通信作者: 薛平
  • 基金资助:
    广州市科学(技术)研究专项一般项目(201607010033)

Extraction and identification of primary macrophages from human hepatocellular carcinoma

Hao Liang1, Juping Xie1, Zhenhui Huang1, Dawei Zhang1, Xiaofeng Jiang1, Ping Xue1,()   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China
  • Received:2019-01-28 Published:2019-06-01
  • Corresponding author: Ping Xue
  • About author:
    Corresponding author: Xue Ping, Email:
引用本文:

梁浩, 谢炬平, 黄镇辉, 张大伟, 蒋小峰, 薛平. 人肝癌组织原代巨噬细胞的提取与鉴定[J]. 中华普通外科学文献(电子版), 2019, 13(03): 180-183.

Hao Liang, Juping Xie, Zhenhui Huang, Dawei Zhang, Xiaofeng Jiang, Ping Xue. Extraction and identification of primary macrophages from human hepatocellular carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(03): 180-183.

目的

研究人肝癌组织原代肿瘤相关性巨噬细胞(TAMs)的提取与鉴定方法。

方法

收集原发性肝癌患者术中切取的肝癌组织标本15份,免疫组织化学染色方法检测肝癌组织中肿瘤相关巨噬细胞表面标志物CD68及CD206的表达。利用机械法和酶消化法结合分离TAMs,贴壁培养24 h后在倒置显微镜下进行细胞形态学观察,利用CD68和CD206作为标志物,流式细胞术鉴定细胞纯度。

结果

癌巢和癌旁组织中均可见CD68、CD206阳性表达,阳性细胞表现为棕褐色;获得一定纯度的原代巨噬细胞,具备巨噬细胞的形态特征,其中CD68单阳性比例为36.29%,CD68和CD206双阳性比例为15.96%。

结论

本研究采用的方法可有效提取和培养人肝癌组织来源的原代TAMs,对进一步研究人类肝癌组织TAMs特性及对肿瘤生物学行为的影响具有重要价值。

Objective

To study the extraction and identification of primary tumor-associated macrophages (TAMs) from human hepatocellular carcinoma (HCC).

Methods

Fifteen hepatocellular carcinoma specimens were collected from patients with primary HCC. Immunohistochemical staining was used to detect the expression of tumor-related macrophage surface markers CD68 and CD206 in HCC tissues. TAMs were separated by mechanical method and enzymatic digestion method. After 24 hours of adherent culture, the cell morphology was observed under inverted microscope. CD68 and CD206 were used as markers to identify the purity of TAMs by flow cytometry.

Results

CD68 and CD206 were positive in the central and adjacent tissues, and the positive cells were brown. A certain purity primary macrophages were obtained with morphological characteristics of macrophages. The single positive rate of CD68 was 36.29%, and the double positive rate of CD68 and CD206 was 15.96%.

Conclusion

The method used in this study can effectively extract and cultivate primary TAMs from human HCC tissues, which is of great value to further study the characteristics of TAMs and their effects on biological behavior of tumors.

图1 肝癌癌巢及癌旁组织免疫组织化学染色结果(酶标抗体法 10×10) A为癌巢组织CD68阳性表达;B为癌旁组织CD68阳性表达;C为癌巢组织CD206阳性表达;D为癌旁组织CD206阳性表达
图2 倒置显微镜下观察到的原代巨噬细胞形态(4×10)
图3 流式细胞术检测巨噬细胞表面抗原CD68和CD206的表达水平
[1]
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis[J]. Cell, 2010, 141(1): 39-51.
[2]
杨柳. 巨噬细胞与肿瘤相关性的研究进展[J]. 南昌大学学报(医学版), 2013, 53(6): 93-96.
[3]
Guo C, Buranych A, Sarkar D, et al. Correction: The role of tumor-associated macrophages in tumor vascularization[J]. Vasc Cell, 2014, 6(1): 2.
[4]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[5]
Atanasov G, Hau HM, Dietel C, et al. Prognostic significance of macrophage invasion in hilar cholangiocarcinoma[J]. BMC Cancer, 2015, 15(1): 790.
[6]
Van Overmeire E, Laoui D, Keirsse J, et al. Mechanisms driving macrophage diversity and pecialization in distinct tumor microenvironments and parallelisms with other tissues[J]. Front Immunol, 2014, 5: 127.
[7]
Martinez-Pomares L. The mannose receptor[J]. J Leukoc Biol, 2012, 92(6): 1177-1186.
[8]
Liu Y, Cao X. The origin and function of tumor-associated macrophages[J]. Cell Mol Immunol, 2014, 12(1): 1-4.
[9]
Schwarz AM, Banning-Eichenseer U, Seidel K, et al. Impact of interleukin-10 on phenotype and gene expression during early monocyte differentiation into dendritic cells[J]. Anticancer Res, 2013, 33(11): 4791-4798.

URL    
[1] 陆宜仙, 张震涛, 夏德萌, 王家林. 巨噬细胞极化在骨质疏松中调控作用及机制的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 538-541.
[2] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[3] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[4] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[5] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[6] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[7] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[8] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[9] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[10] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[11] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[12] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[13] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[14] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
[15] 杨秀君, 崔梦莹, 张丹, 曲仙智, 苗云皓, 盛基尧, 郑戈, 刘水, 张学文. 信迪利单抗联合仑伐替尼成功转化治疗不可切除肝癌一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 581-584.
阅读次数
全文


摘要